Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients

BACKGROUND: Registry data shows that the incidence of acute rejection has been steadily falling. Approximately 10% to 35% of kidney recipients will undergo treatment for at least one episode of acute rejection within the first post‐transplant year. Treatment options include pulsed steroid therapy, t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Webster, Angela C, Wu, Sunny, Tallapragada, Krishna, Park, Min Young, Chapman, Jeremy R, Carr, Sue J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2017
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483358/
https://ncbi.nlm.nih.gov/pubmed/28731207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004756.pub4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller